Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy

Since the World Health Organization (WHO) announced coronavirus 2019 (COVID-19) as a pandemic in March 2020, it has been wreaking havoc across countries, affecting people's lives. Corticosteroids have proven to provide a mortality benefit in patients with COVID-19. Although dexamethasone is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, William, Lim, Frederick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514934/
https://www.ncbi.nlm.nih.gov/pubmed/34659847
http://dx.doi.org/10.1155/2021/5856600
_version_ 1784583505906237440
author Lim, William
Lim, Frederick
author_facet Lim, William
Lim, Frederick
author_sort Lim, William
collection PubMed
description Since the World Health Organization (WHO) announced coronavirus 2019 (COVID-19) as a pandemic in March 2020, it has been wreaking havoc across countries, affecting people's lives. Corticosteroids have proven to provide a mortality benefit in patients with COVID-19. Although dexamethasone is the most commonly used glucocorticoid and have shown to have mortality benefit in COVID-19 patients, it cannot be used in patients with adrenal insufficiency due to its lack of mineralocorticoid activity. Herein, we discuss a case of challenging corticosteroid management in a patient with COVID-19 complicated by her medical history of bilateral adrenalectomy.
format Online
Article
Text
id pubmed-8514934
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-85149342021-10-15 Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy Lim, William Lim, Frederick Case Rep Infect Dis Case Report Since the World Health Organization (WHO) announced coronavirus 2019 (COVID-19) as a pandemic in March 2020, it has been wreaking havoc across countries, affecting people's lives. Corticosteroids have proven to provide a mortality benefit in patients with COVID-19. Although dexamethasone is the most commonly used glucocorticoid and have shown to have mortality benefit in COVID-19 patients, it cannot be used in patients with adrenal insufficiency due to its lack of mineralocorticoid activity. Herein, we discuss a case of challenging corticosteroid management in a patient with COVID-19 complicated by her medical history of bilateral adrenalectomy. Hindawi 2021-10-13 /pmc/articles/PMC8514934/ /pubmed/34659847 http://dx.doi.org/10.1155/2021/5856600 Text en Copyright © 2021 William Lim and Frederick Lim. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Lim, William
Lim, Frederick
Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy
title Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy
title_full Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy
title_fullStr Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy
title_full_unstemmed Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy
title_short Corticosteroid Management of Coronavirus 2019 (COVID-19) in Patients with Bilateral Adrenalectomy
title_sort corticosteroid management of coronavirus 2019 (covid-19) in patients with bilateral adrenalectomy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514934/
https://www.ncbi.nlm.nih.gov/pubmed/34659847
http://dx.doi.org/10.1155/2021/5856600
work_keys_str_mv AT limwilliam corticosteroidmanagementofcoronavirus2019covid19inpatientswithbilateraladrenalectomy
AT limfrederick corticosteroidmanagementofcoronavirus2019covid19inpatientswithbilateraladrenalectomy

Ejemplares similares